The Medyzen blog
Clinical Drug Insights
What a hospital pharmacy needs to stock around a total knee replacement, from anticoagulant prophylaxis to antibiotics, and why availability gaps cost revenue.
Clinical Drug Insights
A clinical overview of knee replacement in India: who actually needs one, implant types, NPPA price caps, and the real recovery timeline doctors should know.
Clinical Drug Insights
The real drug interactions around knee replacement surgery: anticoagulants, NSAID-aspirin timing, and perioperative management doctors need to plan for.
Clinical Drug Insights
Knee replacement cost in India explained through NPPA implant price caps, CGHS package rates and PMJAY package rates, sourced from official notifications.
Clinical Drug Insights
The drug classes used for joint pain in India, what OARSI guidelines actually recommend, and where CDSCO has restricted specific NSAIDs like nimesulide.
Costs & Economics
Is a pharmacy business profitable in India? Real gross vs net margins, setup cost, Jan Aushadhi economics, and what actually eats the profit, sourced.
Clinical Drug Insights
What the evidence says about natural and dietary approaches to iron deficiency in India, where they fall short of supplementation, and the Anemia Mukt Bharat data.
Clinical Drug Insights
Oral and IV iron formulations used for iron deficiency in India, their generic names, NLEM status, and what a hospital pharmacy needs to stock.
Clinical Drug Insights
Why reliable oral and IV iron stocking matters for a hospital pharmacy given India's anaemia burden, and what actually needs to be on the shelf.
Clinical Drug Insights
Iron deficiency guidelines from WHO and India's Anemia Mukt Bharat programme — diagnosis thresholds, target groups, and the oral-vs-IV iron question.
Clinical Drug Insights
Iron deficiency in India by the numbers: NFHS-5 prevalence, oral vs IV iron therapy evidence, Anemia Mukt Bharat strategy, and NPPA-linked cost context for prescribers.
Clinical Drug Insights
Documented drug interactions with oral iron therapy in India, the chelation mechanism behind them, and why they matter given India's anaemia burden.
Clinical Drug Insights
Insulin price in India explained: NPPA ceiling pricing under DPCO, how insulin glargine and analogue prices are set, and where PMBJK generic insulin fits.
Clinical Drug Insights
NPPA ceiling prices for human insulin and insulin analogues in India, Jan Aushadhi access, and what hospital pharmacies need to know about insulin cost.
Revenue
How Tier 2 and Tier 3 hospitals raise revenue without fresh capital: billing recovery, faster discharge, PM-JAY claims, and the pharmacy lever most guides skip.
Models
In-house, managed and franchise hospital pharmacy models compared on cost, control, staffing and revenue, with a decision framework for your facility.
Clinical Drug Insights
How India's hypertension treatment guidelines stage drug therapy, why combination pills are standard, and what IHCI shows about primary-care control.
Setup Guides
The real steps to start a medical store in India: eligibility, drug licence, documents, costs, and a government-backed low-capital alternative.
Setup Guides
Licences, forms, floor area, documents and real costs for opening a hospital pharmacy in India. Form 20 vs 21 explained, plus why applications get rejected.
Compliance
The exact online steps to get a drug licence in India: account creation, form selection, document upload, payment, inspection, and certificate issuance.
Costs & Economics
What a hospital pharmacy actually costs to set up in India: fit-out, inventory, licensing and IT, itemised, with a free calculator to run your own numbers.
Operations
The real operational problems hospital pharmacies face in India, backed by peer-reviewed data, and the practices that actually fix each one.
Clinical Drug Insights
High BP tablets in India by drug class: ACE inhibitors, ARBs, CCBs, diuretics and beta blockers, with NPPA price status and Jan Aushadhi costs.
Compliance
Current GST rates on medicines after the 2025 rate cut, registration thresholds, input tax credit, and how to handle expired stock in your returns.
